UKCA MARKED · CLINICAL STAGE · UK MEDTECH

TRANSFORMING
MOLECULAR
DIAGNOSTICS.

Tachyon is a decentralised molecular diagnostics platform, delivering clinical answers in hours, not weeks. One device — Multiple diagnostic tests.

EXPLORE TACHYON→View Science↓

~15hSame day · Sample to Report

2xValidated technology · Validated panels

UKCAMarket Access

~15hSame day · Sample to Report

2xValidated technology · Validated panels

UKCAMarket Access

vs competitors

SPEED

Same day

Same day vs 4–6 weeks

Benchmark

CLINICAL PROOF

0/10

Proven on real clinical samples · 10/10 matched benchmark results

Market ready

REGULATORY

UKCA +

UKCA + MHRA registered — commercial sale authorised

Consortium

International Clinical Traction

0 Hospitals

3 NHS Trusts · Institutional national clinics in France and Norway

— SEE IT IN ACTION

Tachyon at work.
Real lab. Real results.

Oxford Nanopore 3rd-generation sequencing hardware

Full transcriptome sequencing — same day results

Oxford Nanopore 3rd-generation sequencing

No centralised lab required — point-of-care ready

WATCH LAB DEMO

📍

Location

Conference Room, Dunkirk, France

— DIAGNOSTIC PANELS

One platform. Multiple tests.

Each panel is being independently validated on the Tachyon device core engine.

VALIDATED

Breast Cancer Recurrence

Gene-expression test helps doctors decide if chemotherapy is needed. Clinical feasibility study completed.

· CA mark· Clinical feasibility validated

Readiness100%

IN DEVELOPMENT

Sepsis Diagnostic

Host transcriptomic response panel for rapid sepsis detection and patient stratification.

· 1,000-sample study· Host response· ICU stratification

Readiness20%

VALIDATED

Radiation Exposure

Quantitative full transcriptomic signature for ionising radiation exposure. Dose-range classification in under 7 hours.

· Dose-response classification· Peripheral blood RNA

Readiness100%

— TECHNOLOGY

Full transcriptome. Unlock full omics clinical diagnostics not locked biomarker panels.

Legacy diagnostics rely on fixed panels designed years ago. Tachyon reads the entire transcriptome — capturing biological complexity that short-read competitors miss.

Gene Coverage

HQ Science (Tachyon)

Whole transcriptome

<15h

Point-of-care deployment

No lab required. Works anywhere.

Only Tachyon

Oxford Nanopore · 3rd Generation Sequencing

Long-read sequencing captures full-length transcripts and splice variants invisible to short-read panels.

AI That Improves Over Time

Whole transcriptome analysis means our models can evolve — not locked to a fixed gene panel.

Decentralised — No Lab Required

Nanopore sequencer hardware + Tachyon HPC + software. Brings clinical-grade diagnostics to any location.

UKHSA Harwell Infrastructure

Spin-out with access to high-throughput R&D molecular biology facilities and 1,000 samples/week processing capacity at Harwell Oxford.

— PLATFORM WORKFLOW

Sample to answer. Hours, not weeks.

Sample Processing

Blood, or tissue.

5 hours

Nanopore Sequencing

Full-length transcript capture using Oxford Nanopore 3rd generation. On-device.

1 hour

Tachyon AI Core

Proprietary real-time bioinformatics. Panel-agnostic interpretation.

1 hour

Clinical Report

Validated, auditable output. Regulatory-grade. Ready for clinical decisions.

Total < 24 hours

— TEAM

The people behind Tachyon.

Oncologists, bioinformaticians, and engineers united by a single mission.

Dr Stan Polozov

CEO & Founder

Stan is founder and director at HQ Science Ltd as well as a collaborator scientist at UK Health Security Agency (UKHSA). At HQ Science, he leads a team of reputable scientists, engineers and business developers across the EU and UK to disrupt the field of personalised diagnostics by providing decentralised molecular diagnostics point-of-care solutions to improve clinical outcomes in patients.

Kuby Demirkaya

CFO & Co-founder

Corporate finance expert, 20+ years across industries.

Alex Diatlov

COO

3× tech entrepreneur, 1 exit. Hardware & ops.

Roman Belkin

Chief BD Officer

MedTech entrepreneur and regulatory expert.

Krisztian Spilka

CPO

Serial tech entrepreneur, product background.

Dr Maria Polozova

Research Officer

Maria Polozova, a Research Officer at HQ Science, is a biomedical scientist with a degree in medicine (Clinical Immunologist, M.D.). Maria's diverse skill set contributes significantly to our research capabilities, as well as the development and implementation of advanced diagnostics at HQ Science.

Dr Veronica Goriacha

Bioinformatician & Data Scientist

Veronica Goriacha, a Bioinformatician and Data Scientist at HQ Science, holds an M.Sc. in Applied Mathematics and a PhD in applying informatics, machine learning, and neural networks in medical data analysis.

— PARTNERS & COLLABORATORS

Validated with institutions that matter.

UKHSA research partner. Collaborating with NHS Trusts and research centres across Europe.

🇬🇧

UK Health Security Agency

Spin-out · Harwell Oxford lab · 1,000 samples/week

🏥

3 NHS Trusts · LOIs Signed

Southampton · Grampian · Scotland North

🇫🇷

Centre Oscar Lambret

Feasibility tested

🇳🇴

Oslo University Hospital

Clinical trials · Translational research

READY TO DEPLOY TACHYON?

Partner with HQ Science.

Deploy Tachyon in your clinical laboratory, co-develop a new diagnostic panel, or explore research collaboration with our team.

Get in Touch →

👤

CEO & FOUNDER